Shushan Hovsepyan: Exploring new drugs for ultra-rare cancers?

Shushan Hovsepyan, Pediatric Oncologist and Research Coordinator at Yeolyan Hematology and Oncology Center, posted on X/Twitter:

“Exploring new drugs for ultra-rare cancers? Take ASPS: only 60 cases/year in Europe and just 2 major studies. There is an urgent need for collaboration among researchers, patient groups, industry, and regulators. More in Journal of Clinical Oncology.”

Source: Shushan Hovsepyan/X